Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)

Sarepta Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $152.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 875.4% year-over-year to $152.0 million; the TTM figure through Mar 2026 stood at $152.0 million (up 875.4% YoY), while the FY2025 annual figure was $5.2 million, down 93.51% from the prior year.
• Other Non-Current Assets was $152.0 million for Q1 2026 at Sarepta Therapeutics, up from $5.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $293.1 million in Q3 2022 to a low of $2.1 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $63.0 million across 5 years, with a median of $15.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets soared 8344.94% in 2022, then slumped 99.24% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $163.0 million in 2022, then decreased by 16.08% to $136.8 million in 2023, then tumbled by 41.57% to $79.9 million in 2024, then sank by 93.51% to $5.2 million in 2025, then jumped by 2827.88% to $152.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $152.0 million (Q1 2026), $5.2 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.